DaleGeoffreySchaarMDPhD

PubMed

• A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B-cell or T-cell acute lymphoblastic leukemia: Results ...
  Neil D Palmisiano, Ju-Whei Lee, David F Claxton, Elisabeth M Paietta, Hassan Alkhateeb
  Ejhaem. 2024-10-01
• Universal posttransplant cyclophosphamide after allogeneic transplant, a retrospective single institution study.
  Dennis L Cooper, Jacqueline Manago, Vimal Patel, Dale Schaar, Anne Tyno
  Leukemia Research. 2022-11-01
• 8 citations
  Checkpoint inhibitor immunotherapy during pregnancy for relapsed-refractory Hodgkin lymphoma.
  Andrew M Evens, Justin S Brandt, Cody J Peer, Tyler Yin, Dale Schaar
  American Journal of Hematology. 2022-06-01

Journal Articles

• PDCD2 functions in cancer cell proliferation and predicts relapsed leukemia  
  Barboza, N., Minakhina, S., Medina, D.J., Balsara, B., Greenwood, S., Huzzy, L., Rabson, A.B., Steward, R. and Schaar, D.G., Cancer Biol Ther, 6/1/2013
• A Phase 2 Randomized Multicenter Study of Two Extended Dosing Schedules of Oral Ezatiostat in Low to Intermediate-1 Risk Myelodysplastic Syndrome  
  Raza A, Galili N, Smith SE, Godwin J, Boccia RV, Myint H, Mahadevan D, Mulford D, Rarick M, Brown GL, Schaar D, Faderl S, Komrokji RS, List AF, Sekeres M, Cancer, 4/1/2012
• Accelerated R-COP: A Pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate  
  Levitt, M.J., Gharibo, M., Strair, R., Schaar, D., Rubin, A. and Bertino, J.R., J Chemotherapy, 1/1/2009
• A Phase I Clinical Trial of 12-O-tetradecanoylphorbol-13-acetate for Patients with Relapsed/Refractory Malignancies  
  Schaar, D., Goodell, L., Aisner, J., Cui, X., Han, Z., Chang, R., Martin, J., Grospe, S., Dudek, L., Conney, A., Lin, L., Rubin, E.H. and Strair, R.K., Cancer Chemotherapy Pharmacology, 1/1/2006
• A Call to Action: Cancer in Adolescents and Young Adults: an Unrecognized Healthcare Disparity  
  Gibbon, Darlene G., Schaar, Dale and Kamen, Barton, Journal of Pediatric Hematology and Oncology, 1/1/2006
• 12-O-tetradecanoylphorbol-13-acetate (TPA)-Induced Dual-Specificity Phosphatase Expression and AML Cell Survival  
  Schaar, D.G., Liu, H., Sharma, S., Ting, Y., Martin, J., Krier, C., Ciardella, M., Osman, M., Goodell, L., Notterman, D.A. and Strair, R.K., Leukemia Research, 1/1/2005
• Antineoplastic Effects of Partially HLA-Matched Irradiated Blood Mononuclear Cells in Patients with Renal Cell Carcinoma  
  Strair RK, Schaar D, Medina, D., Todd, M.B., Aisner, J., Dipaola, R.S., Manago, J., Knox, B., Jenkison, A., Senzon, R., Baker, C., Dudek, L., Ciardella, M., Kuriyan, M..., Journal of Clinical Oncology, 1/1/2003
• Administration of a phorbol ester to patients with hematologic malignancies: Preliminary results from a phase I clinical trial of 12-0-tetradecanoylphorbol-13-acetate  
  Strair RK, Schaar D, Goodell L, Aisner J, Chin K-V, Eid J, et al, Clinical Cancer Research, 1/1/2002
• Novel structure of the human GDNF gene  
  Woodbury, D., Schaar, D.G., Ramakrishnan, L. and Black, I.B., Brain Research, 1/1/1998
• The identification of a novel cDNA preferentially expressed in the olfactory-limbic system of the adult rat  
  Schaar, D.G., Varia, M.R., Elkabes, S., Ramakrishnan, L., Dreyfus, C.F. and Black, I.B., Brain Research, 1/1/1996
• Embryonic sensory development: Local expression of neurotrophin-3 and target expression of nerve growth factor  
  Elkabes, S., Dreyfus, C.F., Schaar, D.G. and Black, I.B, J Comp Neurol, 1/1/1994
• Alternative splice forms of the murine T-cell receptor ß transcript in a cytotoxic T-cell line  
  Schaar, D.G., Oh, B.S., Kallay, L.M., Doherty, P.J. and Pan, S., Immunol Invest, 1/1/1990
• Join now to see all

Abstracts/Posters

• Incorporation of Posttransplant Cyclophosphamide (PCy) As Part of Standard Immunoprophylaxis (IP) for All Allogeneic Transplants: A Retrospective, Single Institution S...
  Dale Schaar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Dual-Specificity MAPK Phosphatases (DS-MKPs): novel targets for AML therapy.
  Schaar, D.G., Ting, Y. and Strair, R., Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/2006
• Novel Strategies Targeting Pro-Survival Pathways in AML.
  Schaar, D.G., Liu, H., Sharma, S., Ting, Y., Martin, J., Krier, C., Ciardella, M., Osman, M., Goodell, L., Notterman, D.A. and Strair, R., Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/2005
• Phorbol Ester Therapy for Myelogenous Leukemia.
  Schaar, D.G., Osman, M., Ciardella, M., Goodell, L. and Strair, R.K., Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/2003
• 12-0-tetradecanoylphorbol-13-acetate (TPA)-induced CD9 expression in primary human leukemic cells involves the extracellular signal-regulated kinase (ERK) pathway.
  Schaar, D.G., Osman, M, Goodell, L., Rabson, A. and R. Strair, Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/2002
• 12-0-tetradecanoylphorbol-13-acetate (TPA) for patients with relapsed/refractory hematologic malignancies/bone marrow disorders.
  Schaar, D.G., Conney, A., Goodell, L., Chang, R., Chin, K.V., Rabson, A., Hsu, J., Knox, B., Senzon, R., Ciardella, M. and Strair, R., Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/2001
• Differential display of basic FGF-treated cultured cortical type 1 astrocytes.
  Varia, M.R., Schaar, D.G, Dreyfus, C.F. and Black, I.B., Differential Display Meeting, 1/1/1995
• Differential display of basic FGF-treated cultured cortical type 1 astrocytes.
  Varia, M.R., Schaar, D.G., Dreyfus, C.F. and Black, I.B., Society for Neuroscience 25th Annual Meeting, 1/1/1995
• Characterization of the genomic structure of the mouse APLP1 gene: Insight into the molecular complexity of the synapse.
  Zhong, S., Wu, K., Schaar, D. and Black, I.B., Society for Neuroscience 25th Annual Meeting, 1/1/1995
• Analysis of astrocyte PCR products obtained with degenerative primers to TGF-beta/GDNF.
  Dean, D.O., Schaar, D.G., Dreyfus, C.F. and Black, I.B., Society for Neuroscience 24th Annual Meeting, 1/1/1994
• Basic FGF elicits specific changes in morphology and gene expression in cultured cortical type 1 astrocytes.
  Varia, M.R., Schaar, D.G., Wu, H., Dreyfus, C.F. and Black, I.B., Society for Neuroscience 24th Annual Meeting, 1/1/1994
• Differential expression of a peroxisomal membrane protein gene in type 1 astrocytes identified by a PCR-based subtractive cloning methodology.
  Varia, M.R., Schaar, D.G., Dreyfus, C.F. and Black, I.B., Society for Neuroscience 23rd Annual Meeting, 1/1/1993
• Differential glial gene expression in the rat brain.
  Schaar, D.G., Sherwood, A.C., Sieber, B.-A., Dreyfus, C.F. and Black, I.B., Society for Neuroscience 22nd Annual Meeting, 1/1/1992
• Retrovirus-mediated transfer of human IL-2 into mouse hematopoietic stem cells. Cellular Immunity and the Immunotherapy of Cancer.
  Schaar, D.G. and Pan, S., UCLA Symposia on Molecular and Cellular Biology, 1/1/1990
• Alternative splicing of T-cell receptor beta mRNA.
  Schaar, D.G. and Pan, S., Annual Workshop on Cancer Research in New Jersey, The New Jersey Commission on Cancer Research, 1/1/1989
• Join now to see all

Other

• The expression of a murine cytotoxic T-cell receptor and the lymphokine, interleukin-2, as a result of retrovirus-mediated gene transfer. Ph.D. Thesis. 
  Schaar, D.G.
  1/1/1991